• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.03% Nasdaq Up1.29%

    Antares Pharma Inc. (ATRS)

    -NasdaqCM
    2.41 Down 0.04(1.63%) May 1, 4:00PM EDT
    |After Hours : 2.41 0.00 (0.00%) May 1, 4:29PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Antares Pharma Inc.
    100 Princeton South
    Suite 300
    Ewing, NJ 08628
    United States - Map
    Phone: 609-359-3020
    Website: http://www.antarespharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:93

    Business Summary 

    Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide. The company’s injection products include OTREXUP, a pre-filled methotrexate syringe with Vibex self-injection system to enable rheumatoid arthritis (RA) and psoriasis patients to self-inject methotrexate at home; and Tjet/Zomajet, a needle-free auto injector to deliver human growth hormone treatment to children without the use of a needle. Its transdermal gel products comprise Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder; and Elestrin, a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. The company also offers OTREXUP, an injection for subcutaneous use indicated for adults with severe active RA, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis, as well as Vibex auto injectors. In addition, it is developing Vibex QS T for testosterone replacement therapy for men who have testosterone deficiency; Vibex QS M with an undisclosed drug for treatment of a CNS indication; and disposable pen injectors. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Meda Pharmaceuticals, Inc.; Pfizer Inc; Population Council; and LEO Pharma, Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Antares Pharma Inc.

    Corporate Governance 
    Antares Pharma Inc.’s ISS Governance QuickScore as of Apr 1, 2015 is 7. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 8; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Eamonn P. Hobbs , 56
    Chief Exec. Officer, Pres and Director
    359.00K0.00
    Mr. James E. Fickenscher , 51
    Chief Financial Officer and Sr. VP
    43.00K0.00
    Mr. Robert F. Apple , 48
    Chief Operating Officer and Exec. VP
    401.00K45.00K
    Ms. Jennifer Evans Stacey Esq., 50
    Head of HR, Sr. VP, Gen. Counsel and Sec.
    212.00K0.00
    Mr. Greg Defilippis ,
    VP of Bus. Devel. & Alliances
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders